Navigation Links
Verenium to sponsor and present at the 2013 BIO Pacific Rim Summit on Industrial Biotechnology and Bioenergy
Date:12/2/2013

SAN DIEGO, Dec. 2, 2013 /PRNewswire/ -- Verenium Corporation, now part of BASF, today announced that the Company is a sponsor of the upcoming 2013 BIO Pacific Rim Summit on Industrial Biotechnology and Bioenergy.  The conference takes place December 8 – 11, 2013 in San Diego, California.

James Levine, President and Chief Executive Officer, will speak on a panel, Pac Rim CEO Spotlight on Tuesday, December 10th, 8:00 a.m. – 9:30 a.m. PST.

Verenium will also host a workshop entitled, Blue + White= Green? Exploring Marine Biodiversity and Bringing Sustainable Solutions to Industry on Tuesday, December 10th at 9:45 a.m. PST.  Ken Barrett, Vice President of Strategy and Business Development at Verenium will moderate the panel and Verenium's Vice President of R&D Strategy and Partnerships, David Weiner, Ph.D., will present as part of the panel.

For more information on the BIO Pacific Rim Summit on Industrial Biotechnology and Bioenergy visit http://www.bio.org/pacrim.  

About Verenium
Verenium, now part of BASF, is an industrial biotechnology company focused on developing high-performance enzymes for industrial processes.  Verenium's tailored enzymes are environmentally friendly, making products and processes greener and more cost-effective for industries, including the global food and fuel markets.  Read more at www.verenium.com.

BASF - The Chemical Company
BASF Corporation, headquartered in Florham Park, New Jersey, is the North American affiliate of BASF SE, Ludwigshafen, Germany. BASF has more than 16,600 employees in North America, and had sales of $18.5 billion in 2012. For more information about BASF's North American operations, visit www.basf.us.

BASF is the world's leading chemical company: The Chemical Company. Its portfolio ranges from chemicals, plastics, performance products and crop protection products to oil and gas. We combine economic success with environmental protection and social responsibility. Through science and innovation, we enable our customers in nearly every industry to meet the current and future needs of society. Our products and solutions contribute to conserving resources, ensuring nutrition and improving quality of life. We have summed up this contribution in our corporate purpose: We create chemistry for a sustainable future. BASF had sales of €72.1 billion in 2012 and more than 110,000 employees as of the end of the year. Further information on BASF is available on the Internet at www.basf.com.

Contacts:

Sarah Carmody
Sr. Manager, Corporate Communications
858-431-8581
sarah.carmody@verenium.com


'/>"/>
SOURCE Verenium Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Harwood Feffer LLP Announces Investigation of Verenium Corporation
2. Verenium Enters Agreement To Be Acquired By BASF
3. Verenium To Present At The Rodman & Renshaw Annual Global Investment Conference
4. Verenium Corporation To Announce Second Quarter 2013 Financial Results
5. Verenium Announces Appointment Of Brian Carter As Vice President Of Grain Processing
6. Verenium To Sponsor And Present At The 2013 Bio World Congress On Industrial Biotechnology
7. Verenium To Introduce New Enzyme Product At 2013 International Fuel Ethanol Workshop & Expo
8. Verenium To Present At Two Upcoming Conferences
9. Verenium Corporation to Announce First Quarter 2013 Financial Results
10. Verenium Reports Financial Results For The Fourth Quarter And Year Ended December 31, 2012
11. Verenium Announces Preliminary Financial Results For Fiscal 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm ... Mold) microbial test has received AOAC Research Institute approval 061601. , “This is ... last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The ...
(Date:6/23/2016)...   EpiBiome , a precision microbiome engineering company, ... financing from Silicon Valley Bank (SVB). The financing will ... its drug development efforts, as well as purchase additional ... has been an incredible strategic partner to us – ... would provide," said Dr. Aeron Tynes Hammack , ...
(Date:6/23/2016)... ... ... In a new case report published today in STEM CELLS Translational Medicine, doctors ... being treated for breast cancer benefitted from an injection of stem cells derived from ... frequent side effect of cancer treatment. , Lymphedema refers to the swelling ...
Breaking Biology Technology:
(Date:4/13/2016)... 13, 2016  IMPOWER physicians supporting Medicaid patients in ... new clinical standard in telehealth thanks to a new ... higi platform, IMPOWER patients can routinely track key health ... mass index, and, when they opt in, share them ... to a local retail location at no cost. By ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys ... founding CEO, Barrett Bready , M.D., who returned ... of the original technical leadership team, including Chief Technology ... of Product Development, Steve Nurnberg and Vice President of ... to the company. Dr. Bready served as ...
(Date:3/23/2016)... Massachusetts , March 23, 2016 /PRNewswire/ ... im Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung ... Xura, Inc. (NASDAQ: MESG ), ... bekannt, dass das Unternehmen mit SpeechPro zusammenarbeitet, ... aus der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, ...
Breaking Biology News(10 mins):